Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to take part and have signed a written consent form
- People aged 18 or older
- People whose general health and ability to carry out daily activities falls within a certain range, as measured by a standard oncology scale called ECOG PS 0–2 (confirm with trial site)
- People who have been diagnosed with a gastrointestinal solid tumour (confirmed by lab testing of tissue or cells) and have previously received chemotherapy containing a drug called oxaliplatin, which may have included combined radiation and chemotherapy
- People whose last oxaliplatin treatment was more than 2 weeks before joining the trial
- People who have nerve pain or numbness linked to oxaliplatin treatment, rated at least 4 out of 10 on a pain scale
- People who are currently receiving or have recently finished chemotherapy (for example, certain regimens such as FOLFIRI, 5-fluorouracil, or bevacizumab), as long as those treatments do not include platinum-based or taxane-based drugs
- People who are able to read and understand French
- People who are registered in the French national health care system
Who may not be able to join:
- People who have had acupuncture for managing chemotherapy side effects in the 3 months before joining
- People who have previously received or are currently receiving chemotherapy that includes taxane-based drugs (such as the TFOX regimen)
- People who have a history of significant nerve damage caused by something other than chemotherapy, such as diabetes, alcohol use, infection, hereditary factors, or nutritional deficiency
- People who have a recent history (within 4 weeks before acupuncture begins) of misusing alcohol, prescription medications, or illicit drugs including cannabis, or who have medical, psychological, or social circumstances that might make it difficult to follow the study requirements
- People who have any other unstable condition that, in the treating doctor's judgement, could affect their safety or ability to participate
- People who have severe swelling in their limbs, classified as grade 3 on a standard medical scale (confirm with trial site)
- People who have used herbal medicines within 2 weeks before a scheduled study intervention
- People who are pregnant or breastfeeding
- People who are under state guardianship, legal tutorship, or in the custody of the justice system
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Emmanuelle Kempf, MD, Henri Mondor University Hospital
Phone: 0140298500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
2-point improvement in the global NRS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.